Menu

Recent Developments Leave Off-Label Marketing On Shaky Ground

The U.S. Department of Justices prosecution of pharmaceutical and medical device companies for alleged off-label marketing and the Food and Drug Administrations recent attempt to provide parameters for such marketing means that now, more than ever, pharmaceutical and medical device companies must be wary of the promotional materials they send to doctors.

Click here for a PDF of the full text